Aktuellt
SENASTE
Redeye lowers its forecast and base case valuation of Alelion following a Q2’22 report on the weak side. The changes are sparred by several near-term challenges including financing, postponed customer deliveries, as well as an absence of new orders during the quarter.
LÄS MER
